+39 02 610346.1 - info@newron.com

Latest press releases

  • 21Oct
    US FDA considers Newron’s re-submitted NDA for Xadago® to be a complete, class 2 response to Complete Response Letter PDUFA date March 21, 2017

     

  • 7Oct
    Newron raises CHF26.1 Mio. in a private placement of new shares

     

  • 7Oct
    Newron raises CHF26.1 Mio. in a private placement of new shares

     

  • 6Oct
    Newron launches a private placement of new shares

     

  • 6Oct
    Newron launches a private placement of new shares

     

  • 22Sep
    Newron re-submits US NDA for Xadago® (safinamide)

     

View All

Newron share price

Events

  • 29Nov
    28th Annual Piper Jaffray Healthcare Conference

    November 29 and 30, 2016 - The Lotte New York Palace, New York - USA

  • 22Nov
    German Equity Forum (Deutsches Eigenkapitalforum)

    November 21-23, 2016 - Frankfurt-am-Main - Germany

  • 23Aug
    Bellevue Healthcare Day

    August 23, 2016 - Marriott Hotel, Zurich, Switzerland

View Event Calendar